Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Urederma is a line of over-the-counter topical therapeutic creams developed and manufactured by Mantra Pharma. The formulation contains urea at concentrations of either 10% or 20%, which functions as both a keratolytic and a hydrating agent. By increasing the water-binding capacity of the stratum corneum and promoting the shedding of dead skin cells, Urederma is indicated for the treatment of dry, thickened skin conditions such as ichthyosis and xerosis. It is specifically designed for use on rough areas like the feet, heels, knees, and elbows, providing emollient properties to reduce minor irritation and itching.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Urederma.